Zobrazeno 1 - 10 of 16 pro vyhledávání: '"A.B. Otero"'
1
First Epidemiologic Study in Argentina of the Prevalence of BK Viruria in Kidney Transplant Patients
Autor: L.J. Gaite, M. Acosta, M.C. Freire, Martha Rebolledo Cobos, M. Perez, H. Petrone, L. Potes, Nora Imperiali, J. Ibañez, G. Cremades, R. Luxardo, K. Marinic, G. Valdez, E. Suso, G. Chanta, F. Acosta, R. O. Schiavelli, M.C. Rial, C. Agost Carreño, R. Bonaventura, A. Gutierrez, A.B. Otero, M. Castellanos, J.L. Sinchi, G. Soler Pujol, Pablo Raffaele, E. Maggiora
Publikováno v: Transplantation Proceedings. 46:3010-3014
Background. TheworldwideseroprevalenceofhumanBKpolyomavirus(BKV)inadultsis 80%.About10%e60%ofrenaltransplantrecipientsexperienceBKVinfection,nephropathy of the graft may occur in 5% of the cases, and up to 45% lose the graft. The aim of this work was
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11366b45956d7f4204b4177ab038cb39
https://doi.org/10.1016/j.transproceed.2014.07.009
Zobrazit plný text záznamu
2
Use of everolimus in renal transplant recipients: data from a national registry
Autor: H. Petrone, F. López, I. Gonzalez, R. Cambariere, A.B. Otero, P. Massari, Nora Imperiali, F. Acosta, F. Cicora, Javier Roberti
Publikováno v: Transplantation proceedings. 46(9)
Proliferation signal inhibitors, such as everolimus, offer immunosuppression without the toxicity of calcineurin inhibitors. This descriptive and prospective study reports outcomes at 1 year and predictors of improved estimated glomerular filtration
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf69259a29b551f0381fa8f13bff337e
https://pubmed.ncbi.nlm.nih.gov/25420808
Zobrazit plný text záznamu
3
De novo use of everolimus with elimination or minimization of cyclosporine in renal transplant recipients
Autor: A.B. Otero, G. Aldana, Nuria Saval, P. Errasti, Josep M. Grinyó, F.J.P. Ramos, Antonio Franco, J. Pefaur, Federico Oppenheimer, A.M. Marti-Cuadros, P. Novoa
Publikováno v: Transplantation proceedings. 43(9)
Background The purpose of two similarly designed multicenter, prospective, parallel-group, open-label studies was to evaluate early cyclosporine (CsA) elimination versus minimization from an everolimus-CsA-steroid regimen in de novo renal transplant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c09573c75d67f5aa2aa49bcbd1d09a81
https://pubmed.ncbi.nlm.nih.gov/22099791
Zobrazit plný text záznamu
4
Gastrointestinal (GI)-Specific patient reported outcomes instruments differentiate between renal transplant patients with or without GI symptoms: results from a South American cohort
Autor: Ruben Schiavelli, Ana M Linchenco, Jacqueline Pefaur, A.B. Otero, Luis Gaite, Clemente Raimondi, Mary Kay Margolis, Gerardo Machnicki
Publikováno v: Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, Vol 6, Iss 1, p 53 (2008)
Background Immunosuppressive therapies have burdensome side effects which may lead to sub-therapeutic dosing and non-compliance. Patients on different immunosuppressant regimens may feel less bothered by Gastrointestinal (GI) side effects or report b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f8b15990f6b9a4d722005105293f0b6
https://pubmed.ncbi.nlm.nih.gov/18644133
Zobrazit plný text záznamu
5
Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection
Autor: Gerardo Machnicki, Paul Keown, A.B. Otero, C. Agost Carreño, Lorenzo Toselli, Robert Balshaw
Publikováno v: Transplantation proceedings. 37(2)
Monitoring of cyclosporine (microemulsion CsA) at 2 hours post-dose (C2), a measure of absorption and exposure, appears superior to trough (C0) monitoring for prediction of rejection risk. The purpose of this study was to determine whether C2 was cos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63d6b7f90fb069a793b14cee4b84ed94
https://pubmed.ncbi.nlm.nih.gov/15848560
Zobrazit plný text záznamu
6
TWO-HOUR POST-DOSE CYCLOSPORINE LEVELS IN RENAL TRANSPLANTATION IN ARGENTINA: A COST-EFFECTIVE STRATEGY FOR REDUCING ACUTE REJECTION
Autor: C. Agost Carreño, Lorenzo Toselli, A.B. Otero, Paul Keown, Gerardo Machnicki, Robert Balshaw
Publikováno v: Transplantation. 78:510-511
Monitoring of cyclosporine (microemulsion CsA) at 2 hours post-dose (C2), a measure of absorption and exposure, appears superior to trough (C0) monitoring for prediction of rejection risk. The purpose of this study was to determine whether C2 was cos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0296629a1f79c3e04f30223137051b65
https://doi.org/10.1097/00007890-200407271-01377
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje